Evaluation of Serum Obestatin Level in Rat Model of Diabetic Nephropathy

P Jha, BKL Das, S Shrestha, S Majhi, L Chandra, S Sharma, N Baral, Glycemic status, lipid profile and proteinuria in diabetic nephropathy. Journal of Nepal Medical Association. ,vol. 49, pp. 143- 146 ,(2010) , 10.31729/JNMA.115

Bancha Satirapoj, Nephropathy in Diabetes Advances in Experimental Medicine and Biology. ,vol. 771, pp. 107- 122 ,(2013) , 10.1007/978-1-4614-5441-0_11

Donald W. Cockcroft, Henry Gault, Prediction of Creatinine Clearance from Serum Creatinine Nephron. ,vol. 16, pp. 31- 41 ,(1976) , 10.1159/000180580

P N Viswanathan, Poonam Kakkar, Ballabh Das, A modified spectrophotometric assay of superoxide dismutase. Indian Journal of Biochemistry & Biophysics. ,vol. 21, pp. 130- 132 ,(1984)

Iacopo Gesmundo, Davide Gallo, Enrica Favaro, Ezio Ghigo, Riccarda Granata, Obestatin: a new metabolic player in the pancreas and white adipose tissue. Iubmb Life. ,vol. 65, pp. 976- 982 ,(2013) , 10.1002/IUB.1226

Mitra Basiratnia, Shiva Faghih, Abbas Rezaianzadeh, Mohammad Hassan Eftekhari, Maryam Ranjbar-Zahedani, Comparison of Appetite-regulating Hormones and Body Composition in Pediatric Patients in Predialysis Stage of Chronic Kidney Disease and Healthy Control Group. Iranian Journal of Medical Sciences. ,vol. 40, pp. 27- 33 ,(2015)

H H Nishi, R J Elin, Three turbidimetric methods for determining total protein compared Clinical Chemistry. ,vol. 31, pp. 1377- 1380 ,(1985) , 10.1093/CLINCHEM/31.8.1377

Peng-ying Gu, Dong-mei Kang, Wei-dong Wang, Yan Chen, Zhi-hong Zhao, Hui Zheng, Shan-dong Ye, Relevance of plasma obestatin and early arteriosclerosis in patients with type 2 diabetes mellitus. Experimental Diabetes Research. ,vol. 2013, pp. 563919- 563919 ,(2013) , 10.1155/2013/563919

An-Jing Ren, Qian He, Jing-Song Shi, Zhi-Fu Guo, Xing Zheng, Li Lin, Yang-Kai Wang, Song-Yun Xia, Li-Li Sun, Xin Du, Ying Sun, Lan-Mei Zhang, Wen-Jun Yuan, Association of obestatin with blood pressure in the third trimesters of pregnancy. Peptides. ,vol. 30, pp. 1742- 1745 ,(2009) , 10.1016/J.PEPTIDES.2009.06.016

A. Agnew, D. Calderwood, O.P. Chevallier, B. Greer, D.J. Grieve, B.D. Green, Chronic treatment with a stable obestatin analog significantly alters plasma triglyceride levels but fails to influence food intake; fluid intake; body weight; or body composition in rats. Peptides. ,vol. 32, pp. 755- 762 ,(2011) , 10.1016/J.PEPTIDES.2010.12.005